Hyzaar and Prandin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hyzaar (hydrochlorothiazide; losartan potassium) and Prandin (repaglinide). Common drug interactions include dehydration among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Hyzaar and Prandin. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.

What is Hyzaar?

Hyzaar has active ingredients of hydrochlorothiazide; losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 16,614 Hyzaar users. Check the latest studies of Hyzaar.

What is Prandin?

Prandin has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 4,680 Prandin users. Check the latest studies of Prandin.



On Jul, 14, 2026

53 people who take Hyzaar and Prandin together, and have interactions are studied.

Hyzaar and Prandin drug interactions.

What are the common drug interactions of Hyzaar and Prandin, by gender? *:

female:

  1. Dehydration (dryness resulting from the removal of water)
  2. Diarrhoea
  3. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  4. Pitting oedema (skin discoloration)
  5. Sedation
  6. Throat tightness
  7. Wheezing (a high-pitched whistling sound made while you breath)
  8. Blood glucose decreased
  9. Blood glucose increased
  10. Neuropathy (damage to nerves)

male:

  1. Cardiac failure congestive
  2. Fatigue (feeling of tiredness)
  3. Dizziness
  4. Dry mouth
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Feeling jittery
  7. Hypoxia (low oxygen in tissues)
  8. Intracardiac thrombus (presence of a circumscribed mass with heart wall)
  9. Loss of consciousness
  10. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

What are the common drug interactions of Hyzaar and Prandin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  3. Visual disturbance
  4. Cardiac failure congestive
  5. Cataract (clouding of the lens inside the eye)
  6. Chronic kidney disease
  7. Eye disorder
  8. Glaucoma (increased fluid pressure in the eye with vision loss)
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Proteinuria present

50-59:

  1. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  2. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  3. Hyperlipidaemia (presence of excess lipids in the blood)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Pancreatic carcinoma (pancreatic cancer)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Skin lesion

60+:

  1. Cardiac failure congestive
  2. Oedema peripheral (superficial swelling)
  3. Dehydration (dryness resulting from the removal of water)
  4. Diarrhoea
  5. Disturbance in attention
  6. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  7. Dry mouth
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Dyspnoea (difficult or laboured respiration)
  10. Hypoxia (low oxygen in tissues)

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 9 people, 16.98%
  2. Type 2 Diabetes: 5 people, 9.43%
  3. Oedema (fluid collection in tissue): 5 people, 9.43%
  4. Stress And Anxiety: 3 people, 5.66%
  5. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 5.66%
  6. Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 3 people, 5.66%
  7. Depression: 3 people, 5.66%

* Approximation only. Some reports may have incomplete information.

Do you take Hyzaar and Prandin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hyzaar and Prandin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hyzaar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prandin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hyzaar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prandin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydrochlorothiazide; losartan potassium and repaglinide (the active ingredients of Hyzaar and Prandin, respectively), and Hyzaar and Prandin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: